{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:25:30Z","timestamp":1769844330510,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01524-w","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:41:36Z","timestamp":1734540096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative CT-based morphological heterogeneity for predicting survival in patients with colorectal cancer liver metastases after surgical resection: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Qian","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Cai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Shi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"12","key":"1524_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"KEUM N, GIOVANNUCCI E","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1524_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","volume":"18","author":"J ENGSTRAND","year":"2018","unstructured":"Engstrand J, Nilsson H, Stromberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78.","journal-title":"BMC Cancer"},{"key":"1524_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2318-9-S1-A60","volume":"9","author":"A UZZAU","year":"2009","unstructured":"Uzzau A, Carrer F, Elezi B, et al. Role of surgery in the treatment of liver metastases from colo-rectal cancer in the elderly. BMC Geriatr. 2009;9:S1.","journal-title":"BMC Geriatr"},{"issue":"20","key":"1524_CR4","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.3748\/wjg.v20.i20.6113","volume":"20","author":"O AKGUL","year":"2014","unstructured":"Akgul O, Cetinkaya E, Ersoz S, et al. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20(20):6113\u201322.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1524_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4251\/wjgo.v13.i9.1043","volume":"13","author":"M GUO","year":"2021","unstructured":"Guo M, Jin N, Pawlik T, et al. Neoadjuvant chemotherapy for colorectal liver metastases: a contemporary review of the literature. World J Gastrointest Oncol. 2021;13(9):1043\u201361.","journal-title":"World J Gastrointest Oncol"},{"issue":"8","key":"1524_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"A VAN CUTSEM E, CERVANTES","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422.","journal-title":"Ann Oncol"},{"key":"1524_CR7","doi-asserted-by":"crossref","unstructured":"Egger M E, Cannon R M, Metzger T L, et al. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg. 2013;216(4):845\u201356. discussion 56\u2009\u2013\u20097.","DOI":"10.1016\/j.jamcollsurg.2012.12.037"},{"issue":"36","key":"1524_CR8","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1200\/JCO.2012.45.2854","volume":"30","author":"J SHINDOH","year":"2012","unstructured":"Shindoh J, Loyer E M Kopetzs, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30(36):4566\u201372.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1524_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"E RUBBIA-BRANDT L, GIOSTRA","year":"2007","unstructured":"Rubbia-brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18(2):299\u2013304.","journal-title":"Ann Oncol"},{"issue":"8","key":"1524_CR10","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1245\/s10434-010-0972-9","volume":"17","author":"M KLINGER","year":"2010","unstructured":"Klinger M, Tamandl D, Eipeldauer S, et al. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX\/FOLFOX. Ann Surg Oncol. 2010;17(8):2059\u201365.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1524_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2214\/AJR.11.7910","volume":"199","author":"CHUNG W S","year":"2012","unstructured":"Chung W S, Park M S, Shin S J, et al. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. AJR Am J Roentgenol. 2012;199(4):809\u201315.","journal-title":"AJR Am J Roentgenol"},{"issue":"21","key":"1524_CR12","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1001\/jama.2009.1755","volume":"302","author":"P CHUN Y S, VAUTHEY J N, BOONSIRIKAMC","year":"2009","unstructured":"Chun Y S, Vauthey J N, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009;302(21):2338\u201344.","journal-title":"JAMA"},{"issue":"2","key":"1524_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"AT DAGOGO-JACK I, SHAW","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1524_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/ijc.25114","volume":"127","author":"N GOASGUEN","year":"2010","unstructured":"Goasguen N, DE Chaisemartin C, Brouquet A, et al. Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents. Int J Cancer. 2010;127(5):1028\u201337.","journal-title":"Int J Cancer"},{"issue":"7","key":"1524_CR15","doi-asserted-by":"publisher","first-page":"e1006225","DOI":"10.1371\/journal.pgen.1006225","volume":"12","author":"A SVEEN","year":"2016","unstructured":"Sveen A, Loes I M Alagaratnams, et al. Intra-patient inter-metastatic genetic heterogeneity in Colorectal Cancer as a key determinant of survival after curative liver resection. PLoS Genet. 2016;12(7):e1006225.","journal-title":"PLoS Genet"},{"issue":"11","key":"1524_CR16","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1016\/j.ejca.2013.03.027","volume":"49","author":"M VAN KESSEL C S, SAMIM","year":"2013","unstructured":"Van Kessel C S, Samim M, Koopman M, et al. Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases. Eur J Cancer. 2013;49(11):2486\u201393.","journal-title":"Eur J Cancer"},{"issue":"12","key":"1524_CR17","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.ejso.2019.07.017","volume":"45","author":"V BRUNSELL T H, CENGIJA","year":"2019","unstructured":"Brunsell T H, Cengija V, Sveen A, et al. Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases. Eur J Surg Oncol. 2019;45(12):2340\u20136.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1524_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"P EISENHAUER E A, THERASSE","year":"2009","unstructured":"Eisenhauer E A, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1524_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1245\/s10434-006-9215-5","volume":"14","author":"MS Tsai","year":"2007","unstructured":"Tsai MS, Su YH, Ho MC, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14(2):786\u201394.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1524_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/SLA.0b013e3180603039","volume":"246","author":"S ZAKARIA","year":"2007","unstructured":"Zakaria S, Donohue J H, Que F G, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg. 2007;246(2):183\u201391.","journal-title":"Ann Surg"},{"key":"1524_CR21","doi-asserted-by":"crossref","unstructured":"Primavesi F, Fadinger N, Biggel S, et al. Early response evaluation during preoperative chemotherapy for colorectal liver metastases: combined size and morphology-based criteria predict pathological response and survival after resection. J Surg Oncol; 2019.","DOI":"10.1002\/jso.25796"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01524-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:07:56Z","timestamp":1734541676000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01524-w","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Peking University Cancer Hospital, and the informed consent was waived. All methods were carried out in accordance with relevant guidelines and regulations (declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}